TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NVCT

Nuvectis Pharma Inc

Healthcare · Biotechnology

23.00$ +4.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NVCT
Line item 2020 2021 2022 2023 2024 2025
-9,100.0%
1,145.6%
1,145.6%
2,563.1%
0.0%
18,664.4%
18,664.4%
9,564.4%
-9,100.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?